281 related articles for article (PubMed ID: 15994775)
1. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
Beddows S; Schülke N; Kirschner M; Barnes K; Franti M; Michael E; Ketas T; Sanders RW; Maddon PJ; Olson WC; Moore JP
J Virol; 2005 Jul; 79(14):8812-27. PubMed ID: 15994775
[TBL] [Abstract][Full Text] [Related]
2. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
Beddows S; Franti M; Dey AK; Kirschner M; Iyer SP; Fisch DC; Ketas T; Yuste E; Desrosiers RC; Klasse PJ; Maddon PJ; Olson WC; Moore JP
Virology; 2007 Apr; 360(2):329-40. PubMed ID: 17126869
[TBL] [Abstract][Full Text] [Related]
3. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.
Dey AK; David KB; Klasse PJ; Moore JP
Virology; 2007 Mar; 360(1):199-208. PubMed ID: 17092531
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
Sanders RW; Vesanen M; Schuelke N; Master A; Schiffner L; Kalyanaraman R; Paluch M; Berkhout B; Maddon PJ; Olson WC; Lu M; Moore JP
J Virol; 2002 Sep; 76(17):8875-89. PubMed ID: 12163607
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants.
Li Y; Svehla K; Mathy NL; Voss G; Mascola JR; Wyatt R
J Virol; 2006 Feb; 80(3):1414-26. PubMed ID: 16415019
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.
Kim M; Qiao ZS; Montefiori DC; Haynes BF; Reinherz EL; Liao HX
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):58-67. PubMed ID: 15665645
[TBL] [Abstract][Full Text] [Related]
8. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
[TBL] [Abstract][Full Text] [Related]
9. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.
Schülke N; Vesanen MS; Sanders RW; Zhu P; Lu M; Anselma DJ; Villa AR; Parren PW; Binley JM; Roux KH; Maddon PJ; Moore JP; Olson WC
J Virol; 2002 Aug; 76(15):7760-76. PubMed ID: 12097589
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
Bower JF; Li Y; Wyatt R; Ross TM
Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.
Stamatos NM; Mascola JR; Kalyanaraman VS; Louder MK; Frampton LM; Birx DL; VanCott TC
J Virol; 1998 Dec; 72(12):9656-67. PubMed ID: 9811699
[TBL] [Abstract][Full Text] [Related]
12. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL
Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins.
Grundner C; Li Y; Louder M; Mascola J; Yang X; Sodroski J; Wyatt R
Virology; 2005 Jan; 331(1):33-46. PubMed ID: 15582651
[TBL] [Abstract][Full Text] [Related]
14. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.
Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555
[TBL] [Abstract][Full Text] [Related]
15. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.
Yasmeen A; Ringe R; Derking R; Cupo A; Julien JP; Burton DR; Ward AB; Wilson IA; Sanders RW; Moore JP; Klasse PJ
Retrovirology; 2014 May; 11():41. PubMed ID: 24884783
[TBL] [Abstract][Full Text] [Related]
16. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
[TBL] [Abstract][Full Text] [Related]
17. Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.
Georgiev IS; Joyce MG; Yang Y; Sastry M; Zhang B; Baxa U; Chen RE; Druz A; Lees CR; Narpala S; Schön A; Van Galen J; Chuang GY; Gorman J; Harned A; Pancera M; Stewart-Jones GB; Cheng C; Freire E; McDermott AB; Mascola JR; Kwong PD
J Virol; 2015 May; 89(10):5318-29. PubMed ID: 25740988
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.
Earl PL; Sugiura W; Montefiori DC; Broder CC; Lee SA; Wild C; Lifson J; Moss B
J Virol; 2001 Jan; 75(2):645-53. PubMed ID: 11134278
[TBL] [Abstract][Full Text] [Related]
19. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d.
Bower JF; Yang X; Sodroski J; Ross TM
J Virol; 2004 May; 78(9):4710-9. PubMed ID: 15078953
[TBL] [Abstract][Full Text] [Related]
20. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
